Literature DB >> 32741499

Acute and extended exposure to episodic future thinking in a treatment seeking addiction sample: A pilot study.

Herry Patel1, Michael Amlung2.   

Abstract

Individuals with addictive disorders commonly exhibit a shortened temporal window (shortened period of time an individual can imagine into their own future), which interferes with treatment focusing on long-term sobriety or reductions in use. Episodic future thinking (EFT) involves generating personalized cues related to anticipated, positive future events. EFT has been shown to reduce impulsive decision-making and the reinforcing value of addictive substances; however, this has only been shown in nontreatment samples. The current study examined the feasibility and impact of a 1-week EFT protocol on decision-making and alcohol motivation in a sample of individuals receiving treatment for alcohol use disorder. We randomly assigned twenty-eight individuals currently enrolled in community-based alcohol use disorder treatment to either an EFT protocol or a control episodic recent thinking (ERT) protocol. Participants completed assessments of delay discounting, alcohol demand, craving, self-efficacy, consideration of consequences, and mindfulness at baseline, after 1 week of EFT practice, and at 1-week follow-up. We observed patterns of reductions in alcohol demand indices, delay discounting rates, and an increase in mindfulness after both acute (1 session) and extended (4 sessions) exposure to EFT. These proof-of-concept findings lay the foundation for a randomized controlled trial of EFT as a supplement to addictions treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol use disorder; Episodic future thinking; Episodic recent thinking; Treatment seeking

Mesh:

Year:  2020        PMID: 32741499     DOI: 10.1016/j.jsat.2020.108046

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  6 in total

1.  Development of Goal Management Training+ for Methamphetamine Use Disorder Through Collaborative Design.

Authors:  Alexandra C Anderson; Alex H Robinson; Eden Potter; Bronte Kerley; Daphne Flynn; Dan I Lubman; Antonio Verdejo-García
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

2.  Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol.

Authors:  Rachel Kohn; Anil Vachani; Dylan Small; Alisa J Stephens-Shields; Dorothy Sheu; Vanessa L Madden; Brian A Bayes; Marzana Chowdhury; Sadie Friday; Jannie Kim; Michael K Gould; Mohamed H Ismail; Beth Creekmur; Matthew A Facktor; Charlotte Collins; Kristina K Blessing; Christine M Neslund-Dudas; Michael J Simoff; Elizabeth R Alleman; Leonard H Epstein; Michael A Horst; Michael E Scott; Kevin G Volpp; Scott D Halpern; Joanna L Hart
Journal:  Ann Am Thorac Soc       Date:  2022-02

3.  Future thinking to decrease real-world drinking in alcohol use disorder: Repairing reinforcer pathology in a randomized proof-of-concept trial.

Authors:  Liqa N Athamneh; Jeremiah Brown; Jeffrey S Stein; Kirstin M Gatchalian; Stephen M LaConte; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2021-04-22       Impact factor: 3.492

4.  Effects of episodic future thinking on reinforcement pathology during smoking cessation treatment among individuals with substance use disorders.

Authors:  Ángel García-Pérez; Gema Aonso-Diego; Sara Weidberg; Roberto Secades-Villa
Journal:  Psychopharmacology (Berl)       Date:  2022-01-12       Impact factor: 4.530

5.  Brief Negative Affect Focused Functional Imagery Training Abolishes Stress-Induced Alcohol Choice in Hazardous Student Drinkers.

Authors:  Alexandra Elissavet Bakou; Ruichong Shuai; Lee Hogarth
Journal:  J Addict       Date:  2021-09-17

6.  Virtual reality intervention effects on future self-continuity and delayed reward preference in substance use disorder recovery: pilot study results.

Authors:  Yitong I Shen; Andrew J Nelson; Brandon G Oberlin
Journal:  Discov Ment Health       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.